Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Michael Prout"'
Autor:
Andrew Gomori, Meghann Klowak, Michael Prout, Farid Esfahani, Michael Namaka, Romeo Hizon, Amy Grossberndt, Christine Leong, Michael R. Mulvey, Loressa Klassen, Maria Melanson, Malcolm Doupe, Aneri Gupta, Emma E. Frost
Publikováno v:
Multiple Sclerosis Journal. 17:397-403
Background: Staphylococcus aureus may produce superantigens that can non-specifically activate CD4+ cells to potentially target the myelin basic protein. Objective: This study examined the association between individuals with multiple sclerosis (MS)
Autor:
Michael Prout, Michael Namaka, Andrew Gomori, Meghann Klowak, Maria Melanson, Emma E. Frost, Colin R. Gramlich, Lisa Wong, Malcom Doupe, Amy Grossberndt, Christine Leong, Farid Esfahani, Josee-Anne Le Dorze
Publikováno v:
International Journal of Neuroscience. 120:631-640
Fatigue and cognitive deficits are common symptoms affecting patients with multiple sclerosis.The effects of interferon beta on fatigue and cognitive deficits were assessed in 50 patients with relapsing multiple sclerosis (recruited at a single cente
Autor:
Josee-Anne Le Dorze, Michael Prout, Michael Namaka, Christine Leong, Farid Esfahani, Mike Limerick, Emma E. Frost
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 2 (2010)
Objective To provide a comprehensive overview on the emerging treatments used for the treatment management of multiple sclerosis (MS). Data Sources PubMed, MEDLINE, Cochrane, and Toxnet databases were used to conduct all comprehensive literature sear
Autor:
Amy Grossberndt, Meghann Klowak, Christine Leong, Emma E. Frost, Dana Turcotte, M.J. Melanson, Michael Prout, L. Vuong, S. Andresen, Mike Namaka, Malcolm Doupe, J-A. Le Dorze
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 2011, Iss 3, Pp 449-458 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Background and purposeMitoxantrone (MX) (Novantrone®) is approved in Canada for certain refractory cancers and acute non-lymphocytic leukemias. It has FDA approval as an immunomodulatory agent for use in secondary progressive multiple sclerosis (SPM
Autor:
Bower, Bruce
Publikováno v:
Science News. 5/14/2016, Vol. 189 Issue 10, p13-13. 3/8p.
Autor:
Nieves-Colón, María A.1,2 mnievesc@umn.edu, Blevins, Kelly E.2 blevinske1@gmail.com, Ángel Contreras-Sieck, Miguel3 miguel_contreras@inah.gob.mx, Bravo López, Miriam4 bravolomiriam@gmail.com
Publikováno v:
Cuicuilco Revista de Ciencias Antropológicas. may-ago2021, Vol. 28 Issue 81, p187-223. 37p.
Autor:
Verdugo, Cristina1 (AUTHOR) cverdugo@ucsc.edu, Zhu, Kimberly2 (AUTHOR), Prout, Michael3 (AUTHOR), Broomandkhoshbacht, Nasreen1 (AUTHOR), Galloway, Alison1 (AUTHOR), Fehren‐Schmitz, Lars1 (AUTHOR), Brady, James E.3 (AUTHOR)
Publikováno v:
International Journal of Osteoarchaeology. Jul/Aug2020, Vol. 30 Issue 4, p458-468. 11p.
Publikováno v:
Ancient Mesoamerica; Fall2021, Vol. 32 Issue 3, p545-557, 13p
Autor:
Biesecker, Calvin
Publikováno v:
Defense Daily; 9/6/2011, Vol. 251 Issue 46, p7-7, 1p
Autor:
Melanson, Maria1,2 (AUTHOR), Grossberndt, Amy2 (AUTHOR), Klowak, Meghann2 (AUTHOR), Leong, Christine2 (AUTHOR), Frost, Emma E.2 (AUTHOR), Prout, Michael2 (AUTHOR), Le Dorze, Josee-Anne2 (AUTHOR), Gramlich, Colin2 (AUTHOR), Doupe, Malcom3 (AUTHOR), Wong, Lisa1 (AUTHOR), Esfahani, Farid1 (AUTHOR), Gomori, Andrew1 (AUTHOR), Namaka, Michael1,2 (AUTHOR) namakamp@ms.umanitoba.ca
Publikováno v:
International Journal of Neuroscience. Oct2010, Vol. 120 Issue 10, p631-640. 10p. 2 Diagrams, 4 Charts, 1 Graph.